ICD-10 Code C86.51 | Angioimmunoblastic T-cell lymphoma, in remission Symptoms, Diagnosis, Billing

Angioimmunoblastic T-cell lymphoma (AITL) is a rare type of non-Hodgkin lymphoma characterized by the proliferation of T-cells and associated with immune dysregulation. It often presents with systemic symptoms such as fever, weight loss, and lymphadenopathy. The ICD-10 Code C86.51 is crucial for accurate diagnosis, documentation, and billing, ensuring appropriate treatment and public health reporting.

What is ICD-10 Code C86.51 for Angioimmunoblastic T-cell lymphoma, in remission?

ICD-10 Code C86.51 represents Angioimmunoblastic T-cell lymphoma in remission, indicating a state where the disease is not currently active. This code is used in clinical documentation and billing to signify that the patient has undergone treatment and is currently free from symptoms, facilitating accurate healthcare records and reimbursement processes.

ICD-10 Code C86.51 – Clinical Definition and Explanation of Angioimmunoblastic T-cell lymphoma, in remission

Angioimmunoblastic T-cell lymphoma is a type of peripheral T-cell lymphoma associated with immune system dysfunction. It typically arises from the proliferation of activated T-cells and can lead to significant morbidity if untreated. Medical attention is necessary to manage symptoms and monitor for potential complications.

Key Clinical Features:

• Systemic symptoms such as fever, night sweats, and weight loss.
• Lymphadenopathy, often involving multiple regions.
• Skin rashes or lesions due to immune dysregulation.
• Hematological abnormalities, including anemia and thrombocytopenia.

ICD-10 Code C86.51 for Angioimmunoblastic T-cell lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C86.51 is utilized in SOAP notes to document the patient's remission status, aiding in the assessment of ongoing treatment efficacy and symptom management. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient records.

What Does ICD-10 Code C86.51 for Angioimmunoblastic T-cell lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C86.51 connects subjective patient reports and objective clinical findings to a formal diagnosis of Angioimmunoblastic T-cell lymphoma in remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C86.51 – Angioimmunoblastic T-cell lymphoma, in remission

Management of Angioimmunoblastic T-cell lymphoma in remission focuses on monitoring and supportive care to prevent relapse.

Antibiotic Therapy:

• Not applicable as AITL is not an infectious disease.

Supportive Care:

• Regular follow-up appointments for monitoring.
• Management of symptoms such as fatigue and pain.
• Nutritional support to maintain overall health.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.

How to Document Symptoms of Angioimmunoblastic T-cell lymphoma, in remission (ICD-10 C86.51) in SOAP Notes

Subjective:

• Patient reports feeling well with no current symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous lymphadenopathy now resolved.

Objective:

• Physical examination shows no lymphadenopathy.
• Vital signs within normal limits.
• Laboratory tests indicate stable blood counts.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Angioimmunoblastic T-cell lymphoma, in remission (ICD-10 Code C86.51)

Assessment:

• Diagnosis: Angioimmunoblastic T-cell lymphoma, in remission.
• ICD-10 Code: C86.51.
• No current symptoms or complications noted.

Plan:

• Continue regular follow-up and monitoring.
• Educate patient on signs of potential relapse.
• Schedule next appointment in 3 months.

Treatment & Plan Section for ICD-10 Code C86.51 – Angioimmunoblastic T-cell lymphoma, in remission

• Monitor for signs of relapse through regular follow-ups.
• Provide education on lifestyle modifications to support health.
• Encourage patient to report any new symptoms immediately.
• Maintain a healthy diet and exercise as tolerated.

Using ICD-10 Code C86.51 for Angioimmunoblastic T-cell lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in patient records.
• Use C86.51 in conjunction with other relevant codes for comprehensive billing.
• Document all clinical findings clearly under Subjective (S) and Objective (O).
• Align treatment plans with clinical guidelines to support justified billing.

Related ICD-10 Codes Often Used with Angioimmunoblastic T-cell lymphoma, in remission

• C85.90 – Non-Hodgkin lymphoma, unspecified

ICD-10 Code C86.51 in Medical Billing and Insurance for Angioimmunoblastic T-cell lymphoma, in remission

ICD-10 Code C86.51 is essential for accurate billing in hospital and outpatient settings, particularly for patients in remission.

Billing Notes:

• Document remission status clearly to support claims.
• Use C86.51 in conjunction with treatment codes for comprehensive billing.
• Ensure all relevant clinical information is included in the patient chart.

Common CPT Pairings: